Standard Biotools (LAB) Non-Current Deferred Tax Liability (2014 - 2026)

Standard Biotools (LAB) has 13 years of Non-Current Deferred Tax Liability data on file, last reported at $823000.0 in Q1 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 20.17% year-over-year to $823000.0 in Q1 2026; TTM through Mar 2026 was $823000.0, a 20.17% decrease from a year earlier, with the FY2025 full-year figure at $810000.0, down 89.53% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $823000.0, up from $810000.0 in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for LAB reached as high as $7.7 million in Q4 2024 and fell as low as $620000.0 in Q3 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $1.5 million across 5 years, with a median of $1.0 million in 2025.
• Across the five-year window, Non-Current Deferred Tax Liability slumped 91.42% in 2022 and jumped 820.33% in 2024, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $1.1 million in 2022, then fell by 20.28% to $841000.0 in 2023, then soared by 820.33% to $7.7 million in 2024, then slumped by 89.53% to $810000.0 in 2025, then rose by 1.6% to $823000.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $823000.0 in Q1 2026, $810000.0 in Q4 2025, and $1.1 million in Q3 2025.